http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4003256-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a8588ac2101c73d540192015151d6f0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-432
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-00063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44
filingDate 2020-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0aad525024679b520696a6ca323cb380
publicationDate 2022-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-4003256-A1
titleOfInvention Layered composite for scar treatment and prevention
abstract A layered composite for scar treatment and prevention, the layered composite including a backing section; a drug matrix section; and a skin-interfacing section. The drug matrix section may be disposed between the back section and the skin-interfacing section. The drug matrix section may include pirfenidone in an amount of from about 1 to about 20 mg/cm2. The layered composite may provide greater than about 75% release of the pirfenidone over a period of about 48 to 72 hours. A method for scar treatment and prevention that includes applying a layered composite as described to a burn wound.
priorityDate 2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11983377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5363234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40632
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5367665
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6537134

Total number of triples: 39.